Patents by Inventor Matthew PAUSLEY

Matthew PAUSLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075204
    Abstract: An auto-injector may include a container capable of comprising a medicament; a shuttle coupled to the container and on a horizontal path with a first state and a second state; an energy source configured to release energy to translate the container and to translate the shuttle, preferably the energy source is pressurized fluid from a can; an impediment preventing horizontal movement of the shuttle before activation of the auto-injector; and a needle having a first end configured to extend out of the auto-injector, and a second end configured to extend into the container, wherein the second end of the needle and the container are not in fluid communication with one another before activation of the auto-injector.
    Type: Application
    Filed: June 29, 2023
    Publication date: March 7, 2024
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel HALBIG, Bryan GRYGUS, Trevor LANGLEY, Andrew DUMONT, Bart E. BURGESS, Matthew PAUSLEY, Ross KENYON
  • Publication number: 20220203032
    Abstract: An auto-injector may include a container capable of comprising a medicament; a shuttle coupled to the container and on a horizontal path with a first state and a second state; an energy source configured to release energy to translate the container and to translate the shuttle, preferably the energy source is pressurized fluid from a can; an impediment preventing horizontal movement of the shuttle before activation of the auto-injector; and a needle having a first end configured to extend out of the auto-injector, and a second end configured to extend into the container, wherein the second end of the needle and the container are not in fluid communication with one another before activation of the auto-injector.
    Type: Application
    Filed: December 29, 2021
    Publication date: June 30, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel HALBIG, Bryan GRYGUS, Trevor LANGLEY, Andrew DUMONT, Bart E. BURGESS, Matthew PAUSLEY, Ross KENYON
  • Publication number: 20220193343
    Abstract: An auto-injector may include a housing having a longitudinal axis and a transverse axis, the housing having a shorter dimension along the transverse axis than along the longitudinal axis, wherein the transverse axis is perpendicular to the longitudinal axis; a flowpath having a first end and a second end; and a container enclosing a first fluid, the container extending from a first end toward a second end along or parallel to the longitudinal axis and being movable from a first position to a second position along or parallel to the longitudinal axis, the container being fluidly isolated from the flowpath in the first position and fluidly connected to the flowpath in the second position.
    Type: Application
    Filed: December 29, 2021
    Publication date: June 23, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bart BURGESS, Bryan GRYGUS, Daniel HALBIG, Ross KENYON, Trevor LANGLEY, Jeremy MCNAMARA, Matthew PAUSLEY, Andrew DUMONT, Paige WAECHTER, John BURKE, Martin BONTOFT, Craig MCGARRELL, Scott MARTIN, James Nicholas MOWER, James Cunningham GLENCROSS, James Donald MCLUSKY, Andrew LABAT-ROCHECOUSTE, Tim QUIGG, Matt HILL, Matthew PHILLIPPO, Kirsty WYNNE
  • Publication number: 20220118177
    Abstract: An auto-injector may include a housing having a longitudinal axis and a transverse axis, the housing having a shorter dimension along the transverse axis than along the longitudinal axis, wherein the transverse axis is perpendicular to the longitudinal axis; a flowpath having a first end and a second end; and a container enclosing a first fluid, the container extending from a first end toward a second end along or parallel to the longitudinal axis and being movable from a first position to a second position along or parallel to the longitudinal axis, the container being fluidly isolated from the flowpath in the first position and fluidly connected to the flowpath in the second position.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 21, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bart BURGESS, Bryan GRYGUS, Daniel HALBIG, Ross KENYON, Trevor LANGLEY, Jeremy MCNAMARA, Matthew PAUSLEY, Andrew DUMONT, Paige WAECHTER, John BURKE, Martin BONTOFT, Craig MCGARRELL, Scott MARTIN, James Nicholas MOWER, James Cunningham GLENCROSS, James Donald MCLUSKY, Andrew LABAT-ROCHECOUSTE, Tim QUIGG, Matt HILL, Matthew PHILLIPPO, Kirsty WYNNE
  • Publication number: 20220047420
    Abstract: According to one aspect of the disclosure, an apparatus for manipulating a sclera to facilitate delivery of a medicament to a suprachoroidal space of an eye may include a needle with a sharp distalmost tip, a needle hub connected to a proximal end of the needle, a housing surrounding the needle hub and extending from a proximal end of the needle hub, and an adaptor surrounding a portion of the needle.
    Type: Application
    Filed: August 11, 2021
    Publication date: February 17, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bryan GRYGUS, Matthew PAUSLEY, Megan DeRIDDER, Paige WAECHTER, Prithvi SINGH, Ross KENYON, Sibgat ULLA, Trevor LANGLEY, Bibiana IGLESIAS